Kenneth J Smith

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. pmc Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults
    Kenneth J Smith
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Prev Med 44:373-81. 2013
  2. pmc The potential economic value of a Staphylococcus aureus vaccine for neonates
    Bruce Y Lee
    Applied Modeling, Public Health Computational and Operations Research PHICOR, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Vaccine 28:4653-60. 2010
  3. pmc Cost-effectiveness of pneumococcal polysaccharide vaccine among healthcare workers during an influenza pandemic
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:200-6. 2010
  4. pmc Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza
    Bruce Y Lee
    Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Vaccine 28:5952-9. 2010
  5. pmc Screening cardiac surgery patients for MRSA: an economic computer model
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Department of Biomedical Informatics, University of Pittsburgh, 200 Meyran Ave, Ste 200, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:e163-73. 2010
  6. pmc Economics of influenza vaccine administration timing for children
    Bruce Y Lee
    Public Health Computation and Operations Research PHICOR Group, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:e75-e85. 2010
  7. pmc Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds
    Kenneth J Smith
    University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    Vaccine 28:7620-5. 2010
  8. pmc Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Management, University of Pittsburgh School of Medicine, 200 Meyran Ave, Ste 200, Pittsburgh, PA 15213, USA
    JAMA 307:804-12. 2012
  9. pmc Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania, USA
    Infect Control Hosp Epidemiol 31:598-606. 2010
  10. doi request reprint Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation: a cost-effectiveness analysis from a U.S. perspective
    Allyson M Pishko
    Department of Medicine, Division Hematology Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 4306, USA
    Thromb Haemost 108:303-10. 2012

Detail Information

Publications51

  1. pmc Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults
    Kenneth J Smith
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Prev Med 44:373-81. 2013
    ..The 13-valent pneumococcal conjugate vaccine (PCV13) is approved by the U.S. Food and Drug Administration for adults, but its role in older adults is unclear...
  2. pmc The potential economic value of a Staphylococcus aureus vaccine for neonates
    Bruce Y Lee
    Applied Modeling, Public Health Computational and Operations Research PHICOR, Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Vaccine 28:4653-60. 2010
    ..aureus vaccine for the neonatal population would be strongly cost-effective (and in many situations dominant) over a wide range of vaccine efficacies (down to 10%) for vaccine costs (<or=$500), and S. aureus attack rates (>or=1%)...
  3. pmc Cost-effectiveness of pneumococcal polysaccharide vaccine among healthcare workers during an influenza pandemic
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:200-6. 2010
    ..To assess the usefulness and cost-effectiveness of pneumococcal polysaccharide vaccine (PPV) among healthcare workers compared with nonuse of PPV during an influenza pandemic...
  4. pmc Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza
    Bruce Y Lee
    Applied Modeling, Public Health Computational and Operations Research, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Vaccine 28:5952-9. 2010
    ....
  5. pmc Screening cardiac surgery patients for MRSA: an economic computer model
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Department of Biomedical Informatics, University of Pittsburgh, 200 Meyran Ave, Ste 200, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:e163-73. 2010
    ..To estimate the economic value of preoperative methicillin-resistant Staphylococcus aureus (MRSA) screening and decolonization for cardiac surgery patients...
  6. pmc Economics of influenza vaccine administration timing for children
    Bruce Y Lee
    Public Health Computation and Operations Research PHICOR Group, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Am J Manag Care 16:e75-e85. 2010
    ..To determine how much should be invested each year to encourage and operationalize the administration of influenza vaccine to children before November and how late the vaccine should be offered each year...
  7. pmc Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds
    Kenneth J Smith
    University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    Vaccine 28:7620-5. 2010
    ..Results were sensitive to shorter time horizons, favoring CDC recommendations. We found dual vaccination of all 50-year-olds economically reasonable. Shorter duration models may not fully account for PPV effectiveness...
  8. pmc Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Management, University of Pittsburgh School of Medicine, 200 Meyran Ave, Ste 200, Pittsburgh, PA 15213, USA
    JAMA 307:804-12. 2012
    ..The cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) compared with 23-valent pneumococcal polysaccharide vaccine (PPSV23) among US adults is unclear...
  9. pmc Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania, USA
    Infect Control Hosp Epidemiol 31:598-606. 2010
    ..Although some have recommended universal surveillance for MRSA at hospital admission to identify and to isolate MRSA-colonized patients, there is a need for formal economic studies to determine the cost-effectiveness of such a strategy...
  10. doi request reprint Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation: a cost-effectiveness analysis from a U.S. perspective
    Allyson M Pishko
    Department of Medicine, Division Hematology Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213 4306, USA
    Thromb Haemost 108:303-10. 2012
    ..In conclusion, prophylactic LMWH given to decrease cancer-related mortality, with no conventional indication, appears economically reasonable if its suggested mortality benefit is confirmed in future trials...
  11. pmc The timing of influenza vaccination for older adults (65 years and older)
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Vaccine 27:7110-5. 2009
    ..50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February...
  12. doi request reprint Age, revaccination, and tolerance effects on pneumococcal vaccination strategies in the elderly: a cost-effectiveness analysis
    Kenneth J Smith
    University of Pittsburgh, Pittsburgh, PA, USA
    Vaccine 27:3159-64. 2009
    ..Revaccination strategies for the elderly are less cost-effective, particularly when prior vaccination and vaccine tolerance are considered...
  13. doi request reprint Economic evaluation of standing order programs for pneumococcal vaccination of hospitalized elderly patients
    Donald B Middleton
    Department of Family Medicine, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15232, USA
    Infect Control Hosp Epidemiol 29:385-94. 2008
    ..The purpose of this study was to estimate the cost-effectiveness of SOPs for pneumococcal polysaccharide vaccine (PPV) vaccination for patients 65 years of age or older in 2 types of hospital...
  14. pmc Cost-effectiveness of a program to eliminate disparities in pneumococcal vaccination rates in elderly minority populations: an exploratory analysis
    Constantinos I Michaelidis
    University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    Value Health 16:311-7. 2013
    ..Here, we estimate the cost-effectiveness of a hypothetical national vaccination intervention program designed to eliminate racial disparities in pneumococcal vaccination in the elderly...
  15. pmc Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults
    Kenneth J Smith
    University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
    Vaccine 31:3950-6. 2013
    ..This analysis estimates the cost-effectiveness of pneumococcal vaccination strategies in HIV-infected individuals and in the broader immunocompromised adult group...
  16. pmc Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia
    Kenneth J Smith
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    J Gen Intern Med 28:1157-64. 2013
    ....
  17. pmc Cost-effectiveness of implementing the chronic care model for diabetes care in a military population
    Shihchen Kuo
    Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Diabetes Sci Technol 5:501-13. 2011
    ..The CCM was implemented at U.S. Air Force Wilford Hall Medical Center through the Diabetes Outreach Clinic (DOC) in 2006, but its cost-effectiveness in this setting is unknown...
  18. pmc Cost-effectiveness of pneumococcal and influenza vaccination standing order programs
    Chyongchiou Jeng Lin
    Department of Family Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Am J Manag Care 19:e30-7. 2013
    ..Here we examine the cost-effectiveness of SOPs to improve both pneumococcal and influenza vaccination rates in outpatient settings for individuals 65 years and older...
  19. pmc Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus?
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Department of Biomedical Informatics, School of Medicine, and Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Infect Control Hosp Epidemiol 30:1158-65. 2009
    ..Testing all vascular surgery patients preoperatively for MRSA and attempting to decolonize those who have positive results may be a strategy to prevent MRSA infection. The economic value of such a strategy has not yet been determined...
  20. doi request reprint Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Modeling, School of Medicine, University of Pittsburgh, Pittsburgh, PA, United States
    Vaccine 26:1420-31. 2008
    ..PPV at ages 50/65 may be clinically and, depending on cost-effectiveness criterion used, economically favored over present vaccination recommendations...
  21. doi request reprint Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups
    Constantinos I Michaelidis
    University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States
    Vaccine 29:3525-30. 2011
    ..In an analysis using conservative assumptions, we found that a hypothetical program to ameliorate disparities in influenza vaccination rates has a moderate to high likelihood of being cost-effective...
  22. pmc Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy
    Brian Feingold
    Division of Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    J Card Fail 16:734-41. 2010
    ..Because of differences in heart failure etiology, sudden death rates, and ICD complication rates, these findings may not be applicable to children...
  23. pmc The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach
    Raj C Dedhia
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15203, USA
    Laryngoscope 121:952-60. 2011
    ....
  24. pmc Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies
    Linwah Yip
    Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Clin Endocrinol Metab 97:1905-12. 2012
    ..We hypothesized that FNA molecular testing of two indeterminate categories (follicular lesion of undetermined significance and follicular/Hürthle cell neoplasm) can be cost saving...
  25. doi request reprint Managing mesh exposure following vaginal prolapse repair: a decision analysis comparing conservative versus surgical treatment
    Laura C Skoczylas
    Division of Urogynecology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Int Urogynecol J 24:119-25. 2013
    ..A decision analysis model was developed comparing conservative and surgical treatments in the management of synthetic mesh exposure following vaginal prolapse repair. We hypothesized that surgical excision would be favored...
  26. pmc Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007
    Kenneth J Smith
    University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    Prev Chronic Dis 7:A109. 2010
    ..We assessed the cost-effectiveness of a community-based, modified Diabetes Prevention Program (DPP) designed to reduce risk factors for type 2 diabetes and cardiovascular disease...
  27. doi request reprint A cost-effectiveness analysis of coagulation testing prior to tonsillectomy and adenoidectomy in children
    James D Cooper
    Division of Hematology Oncology BMT, Department of Pediatrics, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15224, USA
    Pediatr Blood Cancer 55:1153-9. 2010
    ..Studies of pre-operative screening have had conflicting results. A decision analysis model was constructed to address the costs and health outcome states of pre-operative screening strategies in children...
  28. pmc To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling
    Bruce Y Lee
    Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
    PLoS ONE 5:e11284. 2010
    ..Due to the unpredictable burden of pandemic influenza, the best strategy to manage testing, such as rapid or polymerase chain reaction (PCR), and antiviral medications for patients who present with influenza-like illness (ILI) is unknown...
  29. doi request reprint Cost-utility analysis of von Willebrand disease screening in adolescents with menorrhagia
    Robert Francis Sidonio
    Division of Pediatric Hematology Oncology, Children s Hospital of Pittsburgh University of Pittsburgh Medical Center, Pittsburgh, PA 15201, USA
    J Pediatr 157:456-60, 460.e1. 2010
    ..To construct a decision analysis model to evaluate the cost utility of von Willebrand disease (VWD) testing in adolescents with menorrhagia...
  30. pmc Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States
    Constantinos I Michaelidis
    University of Pittsburgh School of Medicine, M240 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA
    BMC Public Health 14:718. 2014
    ..Here, we evaluate the cost-effectiveness of four hypothetical vaccination programs designed to eliminate disparities in elderly vaccination rates and differing in the number of interventions...
  31. pmc Optimal approach to improving trauma triage decisions: a cost-effectiveness analysis
    Deepika Mohan
    The CRISMA Laboratory, Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Am J Manag Care 18:e91-e100. 2012
    ..To identify the optimal target of a future intervention to improve physician decision making in trauma triage...
  32. ncbi request reprint Cost-effectiveness of low-molecular-weight heparin for secondary prophylaxis of cancer-related venous thromboembolism
    Drahomir Aujesky
    Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA
    Thromb Haemost 93:592-9. 2005
    ..However, because of the substantial pharmacy costs of extended low-molecular-weight heparin prophylaxis in the US, this treatment is relatively expensive compared with warfarin...
  33. pmc Cost-effectiveness of new antiviral regimens for treatment-naïve U.S. veterans with hepatitis C
    Alexis P Chidi
    Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
    Hepatology 63:428-36. 2016
    ..In probabilistic sensitivity analysis, treating any patient with ombitasvir-based therapy was cost-effective in 70% of iterations at a $50,000/QALY threshold and 65% of iterations at a $100,000/QALY threshold...
  34. ncbi request reprint Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysis
    Kenneth J Smith
    Medicine Hematology Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213 4306, USA
    Thromb Haemost 100:447-52. 2008
    ..In conclusion, screening, counselling and prophylactic AC during high-risk periods in female relatives of FVL carriers is an economically favourable strategy...
  35. pmc The potential economic value of a hookworm vaccine
    Bruce Y Lee
    Public Health Computational and Operations Research, PA, USA
    Vaccine 29:1201-10. 2011
    ..In fact, the most cost-effective intervention strategy may be to combine vaccine with current drug treatment strategies...
  36. pmc Reliability of laparoscopic compared with hysteroscopic sterilization at 1 year: a decision analysis
    Aileen M Gariepy
    Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of General Internal Medicine, Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Obstet Gynecol 118:273-9. 2011
    ..To estimate the probability of successful sterilization after an hysteroscopic or laparoscopic sterilization procedure...
  37. doi request reprint Retropubic and transobturator midurethral slings: a decision analysis to compare outcomes including efficacy and complications
    Jonathan P Shepherd
    Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Urogynecology and Reconstructive Pelvic Surgery, University of Pittsburgh Medical Center, Magee Women s Hospital, Pittsburgh, PA, USA
    Int Urogynecol J 21:787-93. 2010
    ..The objective of this paper is to compare retropubic (RP) and transobturator (TO) midurethral slings using decision analysis techniques...
  38. ncbi request reprint Information primary care physicians want to receive about their hospitalized patients
    Kenneth J Smith
    Department of Medicine, University of Pittsburgh, PA 15213, USA
    Fam Med 44:425-30. 2012
    ..It is unclear what hospital information PCPs would find most valuable in their patients' continuing care, as is how and when they would prefer to receive such information...
  39. ncbi request reprint InterStim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary Incontinence: A Decision Analysis Comparing Outcomes Including Efficacy and Complications
    Jonathan P Shepherd
    From the Division of Urogynecology and Reconstructive Pelvic Surgery, Departments of Obstetrics, Gynecology, and Reproductive Sciences, Urology, and Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
    Female Pelvic Med Reconstr Surg 17:199-203. 2011
    ..Newer modalities, including Botox and InterStim, can be used when antimuscarinics fail. We compare InterStim and Botox using decision analysis...
  40. pmc Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian cancer
    Jamie L Lesnock
    Dept of ObGyn, Division of Gynecologic Oncology, Magee Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Gynecol Oncol 122:473-8. 2011
    ..We sought to evaluate the cost-effectiveness (C/E) of these consolidation strategies...
  41. pmc A predictive model of the economic effects of an influenza vaccine adjuvant for the older adult (age 65 and over) population
    Bruce Y Lee
    Section of Decision Sciences and Clinical Systems Modeling, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States
    Vaccine 27:2251-7. 2009
    ..In a single influenza season, the adjuvant would prevent 496,533 influenza cases, 171,981 hospitalizations, and 70,429 deaths...
  42. doi request reprint Three cost-utility analyses of screening for intracranial hemorrhage in neonates with hemophilia
    Lynn M Malec
    Department of Pediatrics, Division of Hematology Oncology, Children s Hospital of Pittsburgh of UPMC Section of Decision Sciences and Clinical Decisions Modeling, Department of Medicine, University of Pittsburgh, Pittsburgh, PA Department of Pediatrics, Division of Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN
    J Pediatr Hematol Oncol 36:474-9. 2014
    ..Considering the varying sensitivities and costs of various imaging modalities, there remains controversy surrounding universal cranial imaging. Cost-utility analysis is the ideal tool to display the consequences of a decision made...
  43. pmc Cost comparisons between home- and clinic-based testing for sexually transmitted diseases in high-risk young women
    Kenneth J Smith
    Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Infect Dis Obstet Gynecol 2007:62467. 2007
    ..A home testing program could be cost saving, depending on whether changes in clinic testing frequency occur when home testing is available...
  44. doi request reprint Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective
    Craig D Seaman
    Department of Medicine, Division Hematology Oncology, University of Pittsburgh, USA
    Thromb Res 132:647-51. 2013
    ..Rivaroxaban is an oral direct factor Xa inhibitor that is noninferior to warfarin in the prevention of recurrent venous thromboembolism (VTE). Whether rivaroxaban is cost-effective in the prevention of recurrent VTE, however, is not known...
  45. doi request reprint Anticoagulation duration in heterozygous factor V Leiden: a decision analysis
    Anna K Donovan
    Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    Thromb Res 132:724-8. 2013
    ..Among individuals heterozygous for the factor V Leiden mutation, while venous thromboembolism recurrence risk is greater, the risk for bleeding is recognized to be lower, suggesting longer duration anticoagulation could be considered...
  46. pmc Cost-identification analysis of total laryngectomy: an itemized approach to hospital costs
    Raj C Dedhia
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Otolaryngol Head Neck Surg 144:220-4. 2011
    ....
  47. doi request reprint Direct paramedic transport of acute myocardial infarction patients to percutaneous coronary intervention centers: a decision analysis
    Henry E Wang
    Department of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Ann Emerg Med 53:233-240. 2009
    ....
  48. doi request reprint Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis
    Gary Sutkin
    Division of Urogynecology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee Womens Hospital, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA 15213, USA
    Int Urogynecol J Pelvic Floor Dysfunct 20:933-8. 2009
    ..The objective of this study is to estimate efficacy of prophylactic antibiotics in UTI prevention during CISC for postoperative voiding dysfunction after prolapse/incontinence surgery...
  49. doi request reprint Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients
    Emily L Spangler
    University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    J Vasc Surg 52:1537-45.e1-2. 2010
    ..This analysis compares cost-effectiveness of prophylactic vs therapeutic retrievable IVCF placement in high-risk trauma patients...
  50. doi request reprint Cost-effectiveness of endoscopic sphenopalatine artery ligation versus nasal packing as first-line treatment for posterior epistaxis
    Raj C Dedhia
    Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    Int Forum Allergy Rhinol 3:563-6. 2013
    ..Given the morbidity and limited effectiveness of posterior packing, we sought to determine the cost-effectiveness of first-line ESPAL compared to the current practice model...
  51. pmc Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder
    Kenneth J Smith
    Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
    Am J Manag Care 19:e55-63. 2013
    ..Medicare Part D has a drug coverage gap, which imposes risks for discontinuing medications, particularly in mental health disorders where drug costs are high. However, some beneficiaries have generic drug coverage in the gap...